NCT03812081 is a NA clinical trial of Group A : Baska Mask Airway in Baska Mask, sponsored by Cairo University.

Who is sponsoring NCT03812081?

NCT03812081 is sponsored by Cairo University.

What drugs are being tested in NCT03812081?

Interventions in NCT03812081: Group A : Baska Mask Airway, Group B: Proseal Laryngeal Mask Airway.

What condition does NCT03812081 study?

NCT03812081 studies Baska Mask.

Is NCT03812081 still recruiting?

NCT03812081 is currently completed. Last updated 20 February 2019.

Last reviewed 2019-02-20 · How we verify

NCT03812081

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparative Study of the Baska Mask Vs Proseal Laryngeal Mask Regarding Airway Sealing Pressure

Completed NA Last updated 20 February 2019

What this trial tests

NA trial testing Group A : Baska Mask Airway in Baska Mask in 74 participants. Completed in 7 February 2019.

Timeline

5 December 2018

Primary endpoint
5 February 2019

7 February 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	74
Start date	5 December 2018
Primary completion	5 February 2019
Estimated completion	7 February 2019
Sites	1 location across Egypt

Drugs / interventions tested

Group A : Baska Mask Airway
Group B: Proseal Laryngeal Mask Airway

Conditions studied

Baska Mask — all drugs for Baska Mask →

Sponsor

Cairo University

Who can join

Adults 18 to 45, any sex, with Baska Mask. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Baska mask air way(BM) in comparative study with Proseal laryngeal mask airway (PLMA) regarding performance of Baska mask improves the safety and efficacy of airway management for in patients undergoing general anesthesia by mechanical ventilation confirmation of position by fiber optic view of glottis opening and success of gastric tube insertion , Airway sealing pressure, Leak fraction, insertion time and "overall insertion" success rates, and post-operative complications (airway trauma, hoarseness, sore throat and Dysphagia ).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Baska Mask

Currently open trials in the same condition.

NCT06395922 — Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03812081 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 20 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03812081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing